AVGR - Avinger, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Avinger, Inc.

400 Chesapeake Drive
Redwood City, CA 94063
United States
650-241-7900
https://avinger.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full Time Employees71

Key Executives

NameTitlePayExercisedYear Born
Mr. Jeffrey M. SoinskiPres, CEO & Director605.15kN/A1962
Mr. Nabeel P. SubainatiVP of Fin., Principal Financial Officer & Accounting Officer295.85kN/A1984
Mr. Himanshu N. PatelChief Technology Officer423.09kN/A1960
Mr. Keith SchaeferChief Operating OfficerN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, including Ocelot and Tigereye, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is headquartered in Redwood City, California.

Corporate Governance

Avinger, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.